Evidence map›Paper›PMID 12853392›Full record

ArticleClinical and diagnostic laboratory immunology2003

Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adults.

Gillian F Black, Rosemary E Weir, Steven D Chaguluka, David Warndorff, Amelia C Crampin, Lorren Mwaungulu, Lifted Sichali, Sian Floyd, Lyn Bliss, Elizabeth Jarman and 10 more

Open access · diamondAbstract readComparative Study
In one paragraph

Article in Clinical and diagnostic laboratory immunology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 40 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Circulating and Tissue-Resident CD4Gastroenterology · 2017
    Article
  7. Immunological consequences of intragenus conservation of Mycobacterium tuberculosis T-cell epitopes.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. What has Karonga taught us? Tuberculosis studied over three decades.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2009
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 4 countries.

Gillian F BlackKaronga Prevention Study, Chilumba, Malawi.
Rosemary E Weir
Steven D Chaguluka
David Warndorff
Amelia C Crampin
Lorren Mwaungulu
Lifted Sichali
Sian Floyd
Lyn Bliss
Elizabeth Jarman
Linda Donovan
Peter Andersen
Warwick Britton
Glyn Hewinson
Kris Huygen
Jens Paulsen
Mahavir Singh
Ross Prestidge
Paul E M Fine
Hazel M Dockrell
University of London · GBMalawi Epidemiology and Intervention Research Unit · MWCentenary Institute · AUStatens Serum Institut · DK

Funding

Wellcome Trust
6 · The paper itself

Abstract

We have previously shown that young adults living in a rural area of northern Malawi showed greater gamma interferon (IFN-gamma) responses to purified protein derivatives (PPD) prepared from environmental mycobacteria than to PPD from Mycobacterium tuberculosis. In order to define the mycobacterial species to which individuals living in a rural African population have been exposed and sensitized, we tested T-cell recognition of recombinant and purified antigens from M. tuberculosis (38 kDa, MPT64, and ESAT-6), M. bovis (MPB70), M. bovis BCG (Ag85), and M. leprae (65 kDa, 35 kDa, and 18 kDa) in >600 non-M. bovis BCG-vaccinated young adults in the Karonga District of northern Malawi. IFN-gamma was measured by enzyme-linked immunosorbent assay (ELISA) in day 6 supernatants of diluted whole-blood cultures. The recombinant M. leprae 35-kDa and 18-kDa and purified native M. bovis BCG Ag85 antigens induced the highest percentages of responders, though both leprosy and bovine tuberculosis are now rare in this population. The M. tuberculosis antigens ESAT-6 and MPT64 and the M. bovis antigen MPB70 induced the lowest percentages of responders. One of the subjects subsequently developed extrapulmonary tuberculosis; this individual had a 15-mm-diameter reaction to the Mantoux test and responded to M. tuberculosis PPD, Ag85, MPT64, and ESAT-6 but not to any of the leprosy antigens. We conclude that in this rural African population, exposure to M. tuberculosis or M. bovis is much less frequent than exposure to environmental mycobacteria such as M. avium, which have antigens homologous to the M. leprae 35-kDa and 18-kDa antigens. M. tuberculosis ESAT-6 showed the strongest association with the size of the Mantoux skin test induration, suggesting that among the three M. tuberculosis antigens tested it provided the best indication of exposure to, or infection with, M. tuberculosis.

Indexed as

AdolescentAdultAntigens, BacterialBCG VaccineChildFemaleHumansInterferon-gammaLeprosyMalawiMaleMycobacteriumMycobacterium bovisMycobacterium lepraeMycobacterium tuberculosisRecombinant Fusion ProteinsAntigens, BacterialBCG VaccineInterferon-gammaRecombinant Fusion Proteins

Identifiers

PMID12853392
PMCPMC164276
OpenAlexW2140347818

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.